Treatment for hyperprolactenemia is –
**Core Concept**
Hyperprolactinemia is a condition characterized by elevated levels of prolactin, a hormone produced by the pituitary gland. This condition can be caused by various factors, including pituitary tumors, thyroid disorders, and certain medications.
**Why the Correct Answer is Right**
The primary treatment for hyperprolactinemia is to reduce the secretion of prolactin. This can be achieved through dopamine agonists, such as bromocriptine or cabergoline, which stimulate dopamine receptors in the pituitary gland, leading to a decrease in prolactin secretion. Additionally, dopamine agonists can also shrink prolactinomas, a type of pituitary tumor that causes hyperprolactinemia.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because dopamine antagonists, such as metoclopramide, would actually increase prolactin secretion by blocking dopamine receptors in the pituitary gland.
**Option B:** This option is incorrect because estrogen replacement therapy may actually increase prolactin levels, particularly in postmenopausal women, due to the estrogen-induced increase in dopamine receptor sensitivity.
**Option C:** This option is incorrect because surgical resection of the pituitary gland is not a first-line treatment for hyperprolactinemia and is typically reserved for cases where medical therapy has failed or is contraindicated.
**Clinical Pearl / High-Yield Fact**
Dopamine agonists, such as bromocriptine and cabergoline, are the first-line treatment for hyperprolactinemia due to their ability to decrease prolactin secretion and shrink prolactinomas.
**Correct Answer:** D. Dopamine agonists.